Before the in vivo tumor targeted imaging, human umbilical vein endothelial cells (HUVECs, CD105 positive) and MCF-7 human breast cancer cells (CD105 negative) were used for flow cytometry studies to confirm the in vitro CD105 targeting efficiency of the HMSN-ZW800-TRC105. Here, ENG is linked to breast cancer.